Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
730 participants
OBSERVATIONAL
2024-08-25
2027-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HEart trAnsplantation Registry of piTie-Salpetriere University Hospital
NCT03393793
Study of Heart Transplant Rejection
NCT00042614
Cardiovascular Evaluation Before Renal Transplantation
NCT01064674
Heart Failure After Heart Transplantation Due to Chronic Rejection
NCT03808324
Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation
NCT01608477
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will be participant-centered through clinical visits. There will be an admission visit and two additional visits: one at 6 months (V1) and another at 12 months (V2), which will be the closing visit
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart Transplantation
Adults heart transplantation
Non-interventions
Usual care evaluations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-interventions
Usual care evaluations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Heart Transplantation within 30 days of both sexes;
Exclusion Criteria
* In the judgment of the local investigator, any difficulty accessing follow-up visits
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Israelita Albert Einstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando Bacal, PhD
Role: STUDY_CHAIR
Heart Transplantation Coordinator - Hospital Albert Einstein
Henrique A Fonseca, PhD
Role: PRINCIPAL_INVESTIGATOR
Head of Vaccines and Immunobiology Clinical Trial - ARO-EINSTEIN
Iascara Wozniak de Campos, PhD
Role: PRINCIPAL_INVESTIGATOR
Clinical Trialist - ARO - EINSTEIN
Luiz V Rizzo, PhD
Role: PRINCIPAL_INVESTIGATOR
Director - ARO - EINSTEIN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Israelita Albert Einstein
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HESTIA REGISTRY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.